STOCK TITAN

Incyte Genomics Inc (INCY) Net Income by Year

INCY

Incyte Genomics Inc reported $1.3B in net income in fiscal year 2025. This represents an increase of 3846.9% from the prior fiscal year. Over the trailing 12 months, Q2 FY2025 through Q1 FY2026, the same line adds up to $1.4B in net income. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Incyte Genomics Inc has filed alongside them.

FY2025 annual
Net Income $1.3B
YoY +3846.9%
10Y CAGR +69.6%
Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Mar 31, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

INCY Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-KFY1110-K
Net Income$1.4B$1.3B+3846.9%$32.6M-94.5%$597.6M+75.4%$340.7M-64.1%$948.6M+420.8%-$295.7M-166.2%$446.9M+308.2%$109.5M+135.0%-$313.1M-400.5%$104.2M+1495.8%$6.5M+113.5%-$48.5M+41.7%-$83.1M-87.6%-$44.3M+76.2%-$186.5M

TTM is the trailing twelve months, Q2 FY2025 through Q1 FY2026, summed from the four most recent quarterly filings.

INCY Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-QQ2'2310-Q
Net Income$303.3M+91.7%$299.3M+48.8%$424.2M+298.4%$405.0M+191.1%$158.2M-6.7%$201.2M+0.1%$106.5M-37.8%-$444.6M-318.4%$169.5M+681.2%$201.1M+605.5%$171.3M+51.9%$203.5M+26.1%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Incyte Genomics Inc financials

Frequently Asked Questions

What was Incyte Genomics Inc's net income in fiscal year 2025?

Incyte Genomics Inc reported $1.3B in net income in fiscal year 2025.

How fast is Incyte Genomics Inc's net income growing?

Incyte Genomics Inc (INCY) net income rose by 3846.9% year over year, from $32.6M to $1.3B in fiscal year 2025.

What is Incyte Genomics Inc's net income over the last twelve months?

Incyte Genomics Inc (INCY) reported $1.4B in net income over the trailing 12 months, Q2 FY2025 through Q1 FY2026, summed from the four most recent quarterly filings.

Across the 15 fiscal years this page covers, Incyte Genomics Inc (INCY) net income went from -$186.5M in fiscal year 2011 to $1.3B in fiscal year 2025.

Incyte Genomics Inc (INCY) reported $303.3M in net income in Q1 2026. This represents an increase of 91.7% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Incyte Genomics Inc (INCY) reported on that line in every period on record.